Chronic kidney disease – Part 2: The evolution of evidence-based treatments from Stage 1 to 4 (Google Doctor Who?)

Presented by Søren Boysen DVM, Dipl. ACVECC, Serge Chalhoub BSc, DVM, Dipl. ACVIM (SAIM)

Continuing education questionnaire

CE credit: 1

Name

Questions

1. Which of the IRIS CKD stages has the most recommendations? *
2. When first diagnosing a cat with CKD, what treatments should be prioritized? *
3. Which hormone could potentially help diagnose kidney disease the earliest and help with identifying disease progression? *
4. Which phosphate binder is associated with toxicities related to lethargy, weakness and difficulty walking? *
5. What are the primary indications for sucralfate or famotidine in cats with CKD? *
6. What level of renal proteinuria as measured by UPC may be associated with the lowest risk for CKD progression? *
7. Which hormone has been called the hunger hormone? *
8. What is the most serious complication and limiting factor of erythrocyte-stimulating agents? *
9. When should subcutaneous fluids be used? *
10. When it comes to meloxicam usage and CKD, which statement is most accurate? *